Competition Commission acts on white owned pharmaceutical companies for price fixing relating to cancer treatment prices

By BO Staff Writer The Competition Commission has cracked down on three pharmaceutical companies for price fixing relating to the cancer treatment prices. The Commission has initiated separate investigations against Roche Holding AG (Roche), Pfizer Inc (Pfizer) and Aspen Pharmacare Holdings Ltd (Aspen). Roche is a Swiss-owned company which is the second largest pharmaceutical company …